Subscribe
shutterstock_664142593_jonathan_weiss-1
Jonathan Weiss / Shutterstock.com
13 August 2019AmericasSarah Morgan

Fed Circ affirms Eli Lilly victories over cancer drugs

The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta (pemetrexed).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Eli Lilly and Eagle Pharma settle antitrust and infringement claims
18 December 2019   US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.
Americas
SCOTUS refuses to hear Eli Lilly patent win
16 June 2020   The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.
Americas
Eli Lilly seals $1bn genetics deal
17 December 2020   Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
Eli Lilly and Eagle Pharma settle antitrust and infringement claims
18 December 2019   US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.
Americas
SCOTUS refuses to hear Eli Lilly patent win
16 June 2020   The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.
Americas
Eli Lilly seals $1bn genetics deal
17 December 2020   Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.

More on this story

Big Pharma
Eli Lilly and Eagle Pharma settle antitrust and infringement claims
18 December 2019   US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.
Americas
SCOTUS refuses to hear Eli Lilly patent win
16 June 2020   The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.
Americas
Eli Lilly seals $1bn genetics deal
17 December 2020   Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.

More features

Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court